Projects funded by the NCN
Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and biased properties of potential anti-inflammatory and anti-cancer drugs
2022/45/B/NZ7/04246
Keywords:
Histamine receptors allosteric ligands allosteric-orthosteric ligands anti-inflammatory drugs anti-cancer drugs.
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST6_13: Bioinformatics, biocomputing, DNA and molecular computation
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Warszawski, Wydział Chemii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 13
Call: OPUS 23 - announced on 2022-03-28
Amount awarded: 2 941 680 PLN
Project start date (Y-m-d): 2023-01-20
Project end date (Y-m-d): 2027-01-19
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.